Kalbe Farma (Indonesia) provided earnings guidance for the full year 2015. The company expected its full-year 2015 sales to grow 2%-3% year on year and its net profit to fall by 3%-4% year on year, amid slowing macroeconomic conditions.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,565 IDR | +0.64% | +1.62% | -2.80% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.80% | 4.42B | |
+48.59% | 780B | |
+41.76% | 627B | |
+19.96% | 334B | |
+6.94% | 296B | |
+17.60% | 244B | |
-0.41% | 217B | |
+11.54% | 214B | |
+4.34% | 161B | |
-3.52% | 159B |
- Stock Market
- Equities
- KLBF Stock
- News PT Kalbe Farma Tbk.
- Kalbe Farma Provides Earnings Guidance for the Full Year 2015